| Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent A Mazzoni, L Salvati, L Maggi, M Capone, A Vanni, M Spinicci, ... The Journal of clinical investigation 130 (9), 4694-4703, 2020 | 571 | 2020 |
| Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ... Journal of translational medicine 18 (1), 405, 2020 | 153 | 2020 |
| First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 A Mazzoni, N Di Lauria, L Maggi, L Salvati, A Vanni, M Capone, ... The Journal of clinical investigation 131 (12), 2021 | 131 | 2021 |
| Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study A Di Castelnuovo, S Costanzo, A Antinori, N Berselli, L Blandi, R Bruno, ... European Journal of Internal Medicine 82, 38-47, 2020 | 129 | 2020 |
| Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients A Mazzoni, L Maggi, M Capone, M Spinicci, L Salvati, MG Colao, A Vanni, ... European Journal of Immunology 50 (12), 2013-2024, 2020 | 75 | 2020 |
| Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 F Lagi, M Piccica, L Graziani, I Vellere, A Botta, M Tilli, L Ottino, B Borchi, ... Eurosurveillance 25 (17), 2000556, 2020 | 69 | 2020 |
| Prompt predicting of early clinical deterioration of moderate-to-severe COVID-19 patients: usefulness of a combined score using IL-6 in a preliminary study A Vultaggio, E Vivarelli, G Virgili, E Lucenteforte, A Bartoloni, C Nozzoli, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2575-2581. e2, 2020 | 67 | 2020 |
| Treatment algorithm for COVID-19: a multidisciplinary point of view F Galluccio, T Ergonenc, A Garcia Martos, AES Allam, M Perez-Herrero, ... Clinical Rheumatology 39, 2077-2084, 2020 | 65 | 2020 |
| The role of chest CT in deciphering interstitial lung involvement: Systemic sclerosis versus COVID-19 M Orlandi, N Landini, G Sambataro, C Nardi, L Tofani, C Bruni, ... Rheumatology 61 (4), 1600-1609, 2022 | 64 | 2022 |
| Low risk of serological cross-reactivity between dengue and COVID-19 M Spinicci, A Bartoloni, A Mantella, L Zammarchi, GM Rossolini, ... Memorias do Instituto Oswaldo Cruz 115, e200225, 2020 | 60 | 2020 |
| Infection with SARS-CoV-2 variants is associated with different long COVID phenotypes M Spinicci, L Graziani, M Tilli, J Nkurunziza, I Vellere, B Borchi, ... Viruses 14 (11), 2367, 2022 | 51 | 2022 |
| SARS-CoV-2 spike-specific CD4+ T cell response is conserved against variants of concern, including omicron A Mazzoni, A Vanni, M Spinicci, M Capone, G Lamacchia, L Salvati, ... Frontiers in Immunology 13, 801431, 2022 | 42 | 2022 |
| Schistosomiasis, strongyloidiasis and Chagas disease: the leading imported neglected tropical diseases in Italy L Zammarchi, F Gobbi, A Angheben, M Spinicci, D Buonfrate, G Calleri, ... Journal of travel medicine 27 (1), taz100, 2020 | 41 | 2020 |
| SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies A Mazzoni, A Vanni, M Spinicci, G Lamacchia, ST Kiros, A Rocca, ... The Journal of Clinical Investigation 132 (6), 2022 | 40 | 2022 |
| Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment F Bartalesi, D Goletti, M Spinicci, A Cavallo, L Attala, J Mencarini, G Fiori, ... Journal of Infection 66 (4), 346-356, 2013 | 39 | 2013 |
| High prevalence of carriage of mcr-1-positive enteric bacteria among healthy children from rural communities in the Chaco region, Bolivia, September to October 2016 T Giani, S Sennati, A Antonelli, V Di Pilato, T di Maggio, A Mantella, ... Eurosurveillance 23 (45), 1800115, 2018 | 38 | 2018 |
| Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis C Della Bella, M Spinicci, A Grassi, F Bartalesi, M Benagiano, ... PLoS One 13 (6), e0197825, 2018 | 37 | 2018 |
| Delay in schistosomiasis diagnosis and treatment: a multicenter cohort study in Italy A Comelli, N Riccardi, D Canetti, M Spinicci, G Cenderello, P Magro, ... Journal of travel medicine 27 (1), taz075, 2020 | 36 | 2020 |
| Impaired response to first SARS‐CoV‐2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib P Guglielmelli, A Mazzoni, L Maggi, ST Kiros, L Zammarchi, S Pilerci, ... American Journal of Hematology 96 (11), E408, 2021 | 35 | 2021 |
| LIOFeron® TB/LTBI: a novel and reliable test for LTBI and tuberculosis C Della Bella, M Spinicci, HFM Alnwaisri, F Bartalesi, S Tapinassi, ... International Journal of Infectious Diseases 91, 177-181, 2020 | 34 | 2020 |
